CoChat

Vagus-macrophage-hepatocyte link promotes post-injury liver regeneration and whole-body survival through hepatic FoxM1 activation

Open access

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.

Abstract

The liver possesses a high regenerative capacity. Liver regeneration is a compensatory response overcoming disturbances of whole-body homeostasis provoked by organ defects. Here we show that a vagus-macrophage-hepatocyte link regulates acute liver regeneration after liver injury and that this system is critical for promoting survival. Hepatic Foxm1 is rapidly upregulated after partial hepatectomy (PHx). Hepatic branch vagotomy (HV) suppresses this upregulation and hepatocyte proliferation, thereby increasing mortality. In addition, hepatic FoxM1 supplementation in vagotomized mice reverses the suppression of liver regeneration and blocks the increase in post-PHx mortality. Hepatic macrophage depletion suppresses both post-PHx Foxm1 upregulation and remnant liver regeneration, and increases mortality. Hepatic Il-6 rises rapidly after PHx and this is suppressed by HV, muscarinic blockade or resident macrophage depletion. Furthermore, IL-6 neutralization suppresses post-PHx Foxm1 upregulation and remnant liver regeneration. Collectively, vagal signal-mediated IL-6 production in hepatic macrophages upregulates hepatocyte FoxM1, leading to liver regeneration and assures survival.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-07747-0

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Vagal signals are critical for post PHx survival. a Cumulative survival of mice that underwent PHx-sham (n = 26), PHx-HV (n = 26), and HV alone (n = 18). b Representative images of liver sections immunostained for BrdU on days 2, 5, and 7 after sham operation for PHx (SO), PHx-sham, or PHx-HV. Scale bars indicate 100 µm. c BrdU-positive hepatocyte ratios in SO mice (n = 5–6 per group), PHx-sham mice (n = 4–6 per group), and PHx-HV mice (n = 4–6 per group) on postoperative days 2, 5, and 7. The magnified graphs on days 5 and 7 are shown in framed boxes with lowered scale ranges. *P < 0.05; **P < 0.01 assessed by log-rank test with Bonferroni correction (a) or one-way ANOVA followed by Bonferroni’s post hoc test (c). n.s., not significant
Fig. 1 Vagal signals are critical for post PHx survival. a Cumulative survival of mice that underwent PHx-sham (n = 26), PHx-HV (n = 26), and HV alone (n = 18). b Representative images of liver sections immunostained for BrdU on days 2, 5, and 7 after sham operation for PHx (SO), PHx-sham, or PHx-HV. Scale bars indicate 100 µm. c BrdU-positive hepatocyte ratios in SO mice (n = 5–6 per group), PHx-sham mice (n = 4–6 per group), and PHx-HV mice (n = 4–6 per group) on postoperative days 2, 5, and 7. The magnified graphs on days 5 and 7 are shown in framed boxes with lowered scale ranges. *P < 0.05; **P < 0.01 assessed by log-rank test with Bonferroni correction (a) or one-way ANOVA followed by Bonferroni’s post hoc test (c). n.s., not significantCC BY · PubMed Central
Fig. 2 Vagal signals are involved in activation of hepatic FoxM1 after PHx. a Relative expressions of Foxm1, its target genes. and MKi67 in the liver 2 days after SO (n = 4), PHx-sham (n = 6), and PHx-HV (n = 6). b Images of liver extract immunoblottings with anti-FoxM1, Cyclin A2, Cdk1, PLK1, and actin in SO, PHx-sham, and PHx-HV mice on postoperative day 2. Arrowhead indicates bands for FoxM1. Data are presented as means ± SEM. *P < 0.01 assessed by one-way ANOVA followed by Bonferroni’s post hoc test (a). n.s., not significant
Fig. 2 Vagal signals are involved in activation of hepatic FoxM1 after PHx. a Relative expressions of Foxm1, its target genes. and MKi67 in the liver 2 days after SO (n = 4), PHx-sham (n = 6), and PHx-HV (n = 6). b Images of liver extract immunoblottings with anti-FoxM1, Cyclin A2, Cdk1, PLK1, and actin in SO, PHx-sham, and PHx-HV mice on postoperative day 2. Arrowhead indicates bands for FoxM1. Data are presented as means ± SEM. *P < 0.01 assessed by one-way ANOVA followed by Bonferroni’s post hoc test (a). n.s., not significantCC BY · PubMed Central
Fig. 3 FoxM1 activation promotes liver regeneration and whole-body survival. a Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days after surgery in control mice that underwent SO (n = 5) and PHx (n = 5), and iFoxM1LKO mice that underwent PHx (n = 5). b (Upper panels) Representative images of liver sections immunostained for BrdU 2 days after PHx from control and iFoxM1LKO mice. Scale bars indicate 100 µm. (Lower panel) BrdU-positive hepatocyte ratios in control (n = 5) and iFoxM1LKO (n = 5) mice 2 days after PHx. c Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days after SO (n = 5), PHx-sham (n = 6), and PHx-HV (n = 5) in mice receiving Ad-LacZ and after PHx-HV in mice receiving Ad-hFoxM1 (n = 6). d (Upper panels) Representative images of liver sections immunostained for BrdU 2 days after SO, PHx-sham, and PHx-HV from mice receiving Ad-LacZ and after PHx-HV from mice receiving Ad-hFoxM1. Scale bars indicate 100 µm. (Lower panel) BrdU-positive hepatocyte ratios in the liver 2 days after SO (n = 5), PHx-sham (n = 6), and PHx-HV (n = 5) in Ad-LacZ-treated mice and PHx-HV in Ad-hFoxM1-treated mice (n = 6). e Cumulative survival of mice that underwent PHx-sham (n = 21) and PHx-HV (n = 34) procedures after receiving Ad-LacZ and mice that underwent PHx-HV after receiving Ad-hFoxM1 (n = 34). Data are presented as means ± SEM. *P < 0.05; **P < 0.01 assessed by one-way ANOVA followed by Bonferroni’s post hoc test (a, c, d), unpaired t test (b), or log-rank test with Bonferroni correction (e). n.s., not significant
Fig. 3 FoxM1 activation promotes liver regeneration and whole-body survival. a Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days after surgery in control mice that underwent SO (n = 5) and PHx (n = 5), and iFoxM1LKO mice that underwent PHx (n = 5). b (Upper panels) Representative images of liver sections immunostained for BrdU 2 days after PHx from control and iFoxM1LKO mice. Scale bars indicate 100 µm. (Lower panel) BrdU-positive hepatocyte ratios in control (n = 5) and iFoxM1LKO (n = 5) mice 2 days after PHx. c Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days after SO (n = 5), PHx-sham (n = 6), and PHx-HV (n = 5) in mice receiving Ad-LacZ and after PHx-HV in mice receiving Ad-hFoxM1 (n = 6). d (Upper panels) Representative images of liver sections immunostained for BrdU 2 days after SO, PHx-sham, and PHx-HV from mice receiving Ad-LacZ and after PHx-HV from mice receiving Ad-hFoxM1. Scale bars indicate 100 µm. (Lower panel) BrdU-positive hepatocyte ratios in the liver 2 days after SO (n = 5), PHx-sham (n = 6), and PHx-HV (n = 5) in Ad-LacZ-treated mice and PHx-HV in Ad-hFoxM1-treated mice (n = 6). e Cumulative survival of mice that underwent PHx-sham (n = 21) and PHx-HV (n = 34) procedures after receiving Ad-LacZ and mice that underwent PHx-HV after receiving Ad-hFoxM1 (n = 34). Data are presented as means ± SEM. *P < 0.05; **P < 0.01 assessed by one-way ANOVA followed by Bonferroni’s post hoc test (a, c, d), unpaired t test (b), or log-rank test with Bonferroni correction (e). n.s., not significantCC BY · PubMed Central
Fig. 4 Muscarinic signals are involved in acute liver regenerative responses after PHx. a (Upper panels) Representative images of liver sections immunostained for BrdU on day 2 after sham operation for PHx (SO) and PHx in vehicle-treated mice and after PHx in atropine-treated mice. Scale bars indicate 100 µm. (Lower panel) BrdU-positive hepatocyte ratios in SO + vehicle mice (n = 4), PHx + vehicle mice (n = 5), and PHx + atropine mice (n = 5). b Fold changes in hepatic weights 3 days after surgery in PHx + vehicle mice (n = 5) and PHx + atropine mice (n = 5). Hepatic weights were divided by those obtained immediately after surgery. c Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days after SO (n = 4) and PHx (n = 5) in vehicle-treated mice and PHx (n = 5) in atropine-treated mice. *P < 0.05; **P < 0.01 assessed by one-way ANOVA followed by Bonferroni’s post hoc test (a and c) or assessed by unpaired t test (b). n.s., not significant
Fig. 4 Muscarinic signals are involved in acute liver regenerative responses after PHx. a (Upper panels) Representative images of liver sections immunostained for BrdU on day 2 after sham operation for PHx (SO) and PHx in vehicle-treated mice and after PHx in atropine-treated mice. Scale bars indicate 100 µm. (Lower panel) BrdU-positive hepatocyte ratios in SO + vehicle mice (n = 4), PHx + vehicle mice (n = 5), and PHx + atropine mice (n = 5). b Fold changes in hepatic weights 3 days after surgery in PHx + vehicle mice (n = 5) and PHx + atropine mice (n = 5). Hepatic weights were divided by those obtained immediately after surgery. c Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days after SO (n = 4) and PHx (n = 5) in vehicle-treated mice and PHx (n = 5) in atropine-treated mice. *P < 0.05; **P < 0.01 assessed by one-way ANOVA followed by Bonferroni’s post hoc test (a and c) or assessed by unpaired t test (b). n.s., not significantCC BY · PubMed Central
Fig. 5 Macrophages mediate vagus-induced hepatic FoxM1 activation. a (Upper panels) Representative images of liver sections immunostained for F4/80 from mice 24 h after receiving control and clodronate liposomes. Scale bars indicate 100 µm. (Lower panel) Relative gene expressions of F4/80 in the liver 24 h after control (n = 4) and clodronate (n = 4) liposome administration. b Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days after surgery in SO + control mice (n = 6), PHx-sham + control mice (n = 8), PHx-sham + clodronate mice (n = 6), and PHx-HV + clodronate mice (n = 6). c (Left panels) Representative images of liver sections immunostained for BrdU on day 2 in SO + control-, PHx-sham + control-, PHx-sham + clordronate-, and PHx-HV + clodronate mice. Scale bars indicate 100 µm. (Right panel) BrdU-positive hepatocyte ratios in SO + control mice (n = 6), PHx-sham + control mice (n = 8), PHx-sham + clodronate mice (n = 6,) and PHx-HV + clodronate mice (n = 6) 2 days after surgery. d Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days after SO in mice receiving control liposome and Ad-LacZ (n = 6) and PHx in mice receiving control liposome and Ad-LacZ (n = 6), clodronate liposome and Ad-LacZ (n = 6), and clodronate liposome and Ad-hFoxM1 (n = 6). e (Left panels) Representative images of liver sections immunostained for BrdU on day 2 after SO in mice receiving control liposome and Ad-LacZ and PHx in mice receiving control liposome and Ad-LacZ, clodronate liposome and Ad-LacZ, and clodronate liposome and Ad-hFoxM1. Scale bars indicate 100 µm. (Right panel) BrdU-positive hepatocyte ratios in the liver 2 days after SO in mice receiving control liposome and Ad-LacZ (n = 6) and PHx in mice receiving control liposome and Ad-LacZ (n = 6), clodronate liposome and Ad-LacZ (n = 6), and clodronate liposome and Ad-hFoxM1 (n = 6). f Mortality rates within 2 postoperative days in PHx + control mice (n = 15) and PHx + clodronate mice (n = 15). Data are presented as means ± SEM. *P < 0.05; **P < 0.01 assessed by one-way ANOVA followed by Bonferroni’s post hoc test (b, c, d, e) or assessed by unpaired t test (a). n.s., not significant
Fig. 5 Macrophages mediate vagus-induced hepatic FoxM1 activation. a (Upper panels) Representative images of liver sections immunostained for F4/80 from mice 24 h after receiving control and clodronate liposomes. Scale bars indicate 100 µm. (Lower panel) Relative gene expressions of F4/80 in the liver 24 h after control (n = 4) and clodronate (n = 4) liposome administration. b Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days after surgery in SO + control mice (n = 6), PHx-sham + control mice (n = 8), PHx-sham + clodronate mice (n = 6), and PHx-HV + clodronate mice (n = 6). c (Left panels) Representative images of liver sections immunostained for BrdU on day 2 in SO + control-, PHx-sham + control-, PHx-sham + clordronate-, and PHx-HV + clodronate mice. Scale bars indicate 100 µm. (Right panel) BrdU-positive hepatocyte ratios in SO + control mice (n = 6), PHx-sham + control mice (n = 8), PHx-sham + clodronate mice (n = 6,) and PHx-HV + clodronate mice (n = 6) 2 days after surgery. d Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days after SO in mice receiving control liposome and Ad-LacZ (n = 6) and PHx in mice receiving control liposome and Ad-LacZ (n = 6), clodronate liposome and Ad-LacZ (n = 6), and clodronate liposome and Ad-hFoxM1 (n = 6). e (Left panels) Representative images of liver sections immunostained for BrdU on day 2 after SO in mice receiving control liposome and Ad-LacZ and PHx in mice receiving control liposome and Ad-LacZ, clodronate liposome and Ad-LacZ, and clodronate liposome and Ad-hFoxM1. Scale bars indicate 100 µm. (Right panel) BrdU-positive hepatocyte ratios in the liver 2 days after SO in mice receiving control liposome and Ad-LacZ (n = 6) and PHx in mice receiving control liposome and Ad-LacZ (n = 6), clodronate liposome and Ad-LacZ (n = 6), and clodronate liposome and Ad-hFoxM1 (n = 6). f Mortality rates within 2 postoperative days in PHx + control mice (n = 15) and PHx + clodronate mice (n = 15). Data are presented as means ± SEM. *P < 0.05; **P < 0.01 assessed by one-way ANOVA followed by Bonferroni’s post hoc test (b, c, d, e) or assessed by unpaired t test (a). n.s., not significantCC BY · PubMed Central
Fig. 6 Vagal signals increase macrophage IL-6 production after PHx. a Relative gene expressions of Il-6 after surgery in PHx-sham mice (n = 4 per group) and PHx-HV mice (n = 4 per group). b Relative gene expressions of Il-6 after PHx-sham in control liposome-treated (n = 5–6 per group) and clodronate liposome-treated mice (n = 5–6 per group), and after PHx-HV in clodronate liposome-treated mice (n = 5–6 per group). c Relative gene expression of Il-6 in primary macrophages after 4 h of stimulation with vehicle (n = 6), 100 µM carbachol (n = 6), or both 100 µM carbachol and 100 µM atropine (n = 6). d Relative gene expressions of Il-6 after PHx in vehicle-treated (n = 4 per group) and atropine-treated (n = 4 per group) mice. *P < 0.05; **P < 0.01 assessed by unpaired t test (a and d), or assessed by one-way ANOVA followed by Bonferroni’s post hoc test (b and c). n.s., not significant
Fig. 6 Vagal signals increase macrophage IL-6 production after PHx. a Relative gene expressions of Il-6 after surgery in PHx-sham mice (n = 4 per group) and PHx-HV mice (n = 4 per group). b Relative gene expressions of Il-6 after PHx-sham in control liposome-treated (n = 5–6 per group) and clodronate liposome-treated mice (n = 5–6 per group), and after PHx-HV in clodronate liposome-treated mice (n = 5–6 per group). c Relative gene expression of Il-6 in primary macrophages after 4 h of stimulation with vehicle (n = 6), 100 µM carbachol (n = 6), or both 100 µM carbachol and 100 µM atropine (n = 6). d Relative gene expressions of Il-6 after PHx in vehicle-treated (n = 4 per group) and atropine-treated (n = 4 per group) mice. *P < 0.05; **P < 0.01 assessed by unpaired t test (a and d), or assessed by one-way ANOVA followed by Bonferroni’s post hoc test (b and c). n.s., not significantCC BY · PubMed Central
Fig. 7 IL-6 mediates vagal signal-induced hepatic FoxM1 activation. a Relative expressions of Foxm1, its target genes, and MKi67 in primary hepatocytes isolated from control and iFoxM1LKO mice treated with 100 ng/ml IL-6 (n = 7–8 per group) and vehicle (n = 7–8 per group) for 6 h. b (Left panels) Representative images of liver extract immunoblottings with anti-phospho-STAT3, total STAT3, and actin. (Right panel) Relative intensities of phospho/total STAT3 in livers from sham operation for PHx (SO)- (n = 6), PHx-sham- (n = 6), and PHx-HV mice (n = 6). c Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days after surgery from SO + IgG (n = 5), PHx + IgG (n = 5), and PHx + anti-IL-6 antibody- (n = 5) treated mice. Data are presented as means ± SEM. *P < 0.05; **P < 0.01 assessed by unpaired t test (a), or assessed by one-way ANOVA followed by Bonferroni’s post hoc test (b and c). n.s., not significant
Fig. 7 IL-6 mediates vagal signal-induced hepatic FoxM1 activation. a Relative expressions of Foxm1, its target genes, and MKi67 in primary hepatocytes isolated from control and iFoxM1LKO mice treated with 100 ng/ml IL-6 (n = 7–8 per group) and vehicle (n = 7–8 per group) for 6 h. b (Left panels) Representative images of liver extract immunoblottings with anti-phospho-STAT3, total STAT3, and actin. (Right panel) Relative intensities of phospho/total STAT3 in livers from sham operation for PHx (SO)- (n = 6), PHx-sham- (n = 6), and PHx-HV mice (n = 6). c Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days after surgery from SO + IgG (n = 5), PHx + IgG (n = 5), and PHx + anti-IL-6 antibody- (n = 5) treated mice. Data are presented as means ± SEM. *P < 0.05; **P < 0.01 assessed by unpaired t test (a), or assessed by one-way ANOVA followed by Bonferroni’s post hoc test (b and c). n.s., not significantCC BY · PubMed Central
Fig. 8 The proposed mechanism of vagus-mediated liver regeneration. The multistep regulatory mechanism of acute liver regeneration after PHx via a vagus–macrophage–hepatocyte link
Fig. 8 The proposed mechanism of vagus-mediated liver regeneration. The multistep regulatory mechanism of acute liver regeneration after PHx via a vagus–macrophage–hepatocyte linkCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 1

  1. Higgins, G. M. & Anderson, R. M. Experimental pathology of the liver VII restoration of the liver after partial surgical removal and ligation of the bile duct in white rats. Arch. Pathol. 14, 42–49 (1932).

Cited by

See all 116

Metadata

Authors
Izumi, T., Imai, J., Yamamoto, J., Kawana, Y., Endo, A., Sugawara, H., Kohata, M., Asai, Y., Takahashi, K., Kodama, S., Kaneko, K., Gao, J., Uno, K., Sawada, S., Kalinichenko, V. V., Ishigaki, Y., Yamada, T., & Katagiri, H.
Affiliations
  • Tohoku University (JP)
  • Cincinnati Children's Hospital Medical Center (US)
  • Iwate Medical University (JP)
Corresponding author
Imai, Junta
Venue
Nature Communications
Published
2018-12-13
Volume
9
Issue
1
Pages
5300-5300
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2904853278
Cited by
109
References
46
Citations by year
2026: 7 · 2025: 15 · 2024: 19 · 2023: 29 · 2022: 16 · 2021: 11 · 2020: 9 · 2019: 3
FWCI
3.60
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
Funders
  • Japan Agency for Medical Research and Development (JP17gm5010002, CREST, 17gm0610001h0006)
  • University of Illinois at Urbana-Champaign
  • University of Illinois at Chicago
  • Japan Society for the Promotion of Science (18H02858, 16K15486, 17H01565, 18K16221, CREST, 17K09816)
  • National Heart, Lung, and Blood Institute (R01HL141174)
  • Institute of Genetics
  • Core Research for Evolutional Science and Technology
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
Keywords
liver regeneration, vagus nerve, hepatic macrophages, FOXM1, partial hepatectomy, vagotomy, hepatocyte proliferation, interleukin-6, muscarinic receptors, liver inflammation, vagal signaling
MeSH terms
Forkhead Box Protein M1, Animals, Enzyme Activation, Hepatectomy, Liver, Liver Regeneration, Macrophages, Male, Mice, Inbred C57BL, Vagus Nerve, Signal Transduction, Interleukin-6, Mice, Knockout, Muscarinic Antagonists, Hepatocytes, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vagus-macrophage-hepatocyte link promotes post-injury liver regeneration and whole-body survival through hepatic FoxM1 activation. https://app.cochat.ai/papers/10.1038/s41467-018-07747-0
The paper
Izumi, T., Imai, J., Yamamoto, J., Kawana, Y., Endo, A., Sugawara, H., Kohata, M., Asai, Y., Takahashi, K., Kodama, S., Kaneko, K., Gao, J., Uno, K., Sawada, S., Kalinichenko, V. V., Ishigaki, Y., Yamada, T., & Katagiri, H. (2018). Vagus-macrophage-hepatocyte link promotes post-injury liver regeneration and whole-body survival through hepatic FoxM1 activation. Nature Communications. https://doi.org/10.1038/s41467-018-07747-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.